[Federal Register Volume 66, Number 115 (Thursday, June 14, 2001)]
[Notices]
[Page 32359]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-14930]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


A Conversation About Cancer Drug Development With Cancer Patient 
Advocates

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

    The Food and Drug Administration (FDA) is announcing the following 
meeting: A Conversation About Cancer Drug Development With Cancer 
Patient Advocates. The topics to be discussed are: Fast track, 
compassionate use, quality of life, the Patient Consultant Program, and 
other issues as they arise.
    Date and Time: The meeting will be held on June 29, 2001, 2 p.m. to 
4 p.m.
    Location: The meeting will be held at the Westin Fairfax Hotel, 
Whitehall Room, 2100 Massachusetts Ave. NW., Washington, DC 20008, 202-
293-2100.
    Contacts: Patricia C. Delaney and JoAnn M. Minor, Office of Special 
Health Issues, Cancer Liaison Program, Office of International and 
Constituent Relations, Office of the Commissioner, Food and Drug 
Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-4460, 
FAX: 301-443-4555, or e-mail: [email protected] and 
[email protected].
    Registration: Send registration information (including name, title, 
firm name, address, telephone, fax number and/or e-mail address) to 
either contact person by June 22, 2001.
    If you need special accommodations due to a disability, please 
contact Patricia C. Delaney or JoAnn M. Minor at least 7 days in 
advance.

    Dated: June 8, 2001.
Margaret M. Dotzel,
Associate Commissioner for Policy.
[FR Doc. 01-14930 Filed 6-13-01; 8:45 am]
BILLING CODE 4160-01-S